A newly issued alert links certain FreeStyle Libre 3 and 3 Plus glucose-monitoring sensors to at least seven deaths and ...
About 3 million glucose monitoring sensors were potentially affected by a production error that caused incorrect low glucose readings.
The Food and Drug Administration has issued an alert concerning two glucose monitors with a “high-risk” sensor issue. Abbott Diabetes Care initiated a “medical device correction” on Nov. 24, for ...
Econostrum on MSN
Major recall of FreeStyle Libre devices: How this could impact your diabetes treatment
The decision to recall approximately three million sensors follows reports of potentially life-threatening errors in the ...
The U.S. Food and Drug Administration warned people to stop using certain types of glucose monitor sensors that were linked ...
Health on MSN
Check Your Continuous Glucose Monitor—Abbott Warns of Potential Incorrect Readings For 3 Million Products
Abbott has warned that 3 million of its continuous glucose monitors may provide incorrect low readings. Here's what to know.
Data analyses show that people with Type 2 diabetes using GLP-1 medicines saw a significant improvement in their HbA1C after adding FreeStyle Libre technology to their regimen Better HbA1c results ...
They say a rising tide lifts all boats, and that certainly seems to be the case with the new wave of drugs and devices for diabetes management. In a recent analysis (PDF), Abbott examined trends in ...
A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...
Abbott has received CE Mark clearance for the second generation of its Freestyle Libre device, which will allow the company to make the device available to users in Europe. It will be rolled out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback